Joshua Schafer insider trades

Open-market stock purchases and sales by Joshua Schafer, CCO at Zevra Therapeutics, Inc, from SEC Form 4 filings since Jan 9, 2023.

Track record: 100% of 3 scored buys are up 5% or more since purchase, averaging +141%.

Recent trades

DateStockTradeValue
Feb 3, 2026ZVRA Zevra Therapeutics, IncSold$96.5K
Jan 31, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 30, 2026ZVRA Zevra Therapeutics, IncSold$29.8K
Jan 30, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—
Jan 29, 2026ZVRA Zevra Therapeutics, IncBought (not open market)—

Companies traded

  • ZVRA Zevra Therapeutics, Inc: 3 buys, 3 sales, last Feb 3, 2026
  • KMPH Kempharm, Inc: other filings, last Jan 9, 2023

Get free alerts when Joshua Schafer files a new trade →